arrow
M

Marisa Pardal

AstraZeneca
H指数:7
被引数:163

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme
2024-04-046
OAAI
Asthma outcomes in patients (pts) with severe eosinophilic asthma (SEA), with and without comorbid chronic rhinosinusitis with nasal polyps (NP), treated with benralizumab in the real-world XALOC-1 study
2023-10-270
PRE
Late Breaking Abstract - Patients with severe eosinophilic asthma achieved remission over 2 years with benralizumab: Integrated analysis of the >1000-patient, multinational, real-world XALOC-1 study
2023-10-271
PRE
Prevalence and Characterisation of Patients with Asthma According to Disease Severity in Portugal Findings from the EPI-ASTHMA Pilot Study

葡萄牙哮喘患者根据疾病严重程度的患病率和特征

2022-10-014
OAAI